MedPath

VORANIGO

VORANIGO

Approved
DIN Number

02551233

Drug Class

Human

Market Date

Oct 21, 2024

Company
HC

servier canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02551233
AIG Number0166124002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01X OTHER ANTINEOPLASTIC AGENTS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

VORASIDENIBActive
Strength: 40 MG
Monograph: VORASIDENIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.